These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5437326)

  • 1. A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function.
    Salmon GK; Ireson JD
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):60-4. PubMed ID: 5437326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central nervous sympathetic depressant effects of alpha-methyldopa].
    Tauberger G; Kuhn P
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(1):33-43. PubMed ID: 4250102
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for an inhibitory action of methyldopa on spinal sympathetic reflexes.
    Baum T; Shropshire AT
    Eur J Pharmacol; 1977 Dec; 46(3):259-63. PubMed ID: 590335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings].
    Fozard JR; Palfreyman MG; Spedding M; Wagner J; Woodward JK
    Br J Pharmacol; 1979 Nov; 67(3):461P. PubMed ID: 497578
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of methyldopa treatment on peripheral sympathetic nerve function in the dog.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1975; 32(02):170-8. PubMed ID: 1097259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):186-93. PubMed ID: 5492891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alpha-methyldopa on sympathetic nerve function in the pithed rat.
    Doxey JC; Scutt A
    Eur J Pharmacol; 1974 Dec; 29(2):320-3. PubMed ID: 4442449
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
    Baum T; Shropshire AT; Varner LL
    J Pharmacol Exp Ther; 1972 Jul; 182(1):135-44. PubMed ID: 5041650
    [No Abstract]   [Full Text] [Related]  

  • 10. Further evidence for a central hypotensive action of -methyldopa.
    Finch L; Haeusler G
    Br J Pharmacol; 1972 May; 45(1):167P-168P. PubMed ID: 5041484
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of reserpine, aldomet and ornid on the transmission of excitability from the sympathetic nerves on the vessles].
    Kisin IE
    Farmakol Toksikol; 1966; 29(6):652-7. PubMed ID: 6000359
    [No Abstract]   [Full Text] [Related]  

  • 14. [New concepts on central regulation of the blood pressure. Mode of action of clonidine and alpha-methyl DOPA (author's transl)].
    Kobinger W
    Wien Klin Wochenschr; 1977 Apr; 89(8):253-7. PubMed ID: 193305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
    Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
    J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methyldopa on the neurogenic component of the arterial blood pressure.
    Gomez HJ; Gomez B; Bonilla LJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):373-82. PubMed ID: 4342314
    [No Abstract]   [Full Text] [Related]  

  • 17. Site of action of methyldopa in lowering the blood pressure in man.
    Kersting F; Reid JL; Dollery CT
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of the cardiovascualr effects of methyldopa.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1976 May; 37(1):79-89. PubMed ID: 6292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance.
    Mohammed S; Gaffney TE; Yard AC; Gomez H
    J Pharmacol Exp Ther; 1968 Apr; 160(2):300-7. PubMed ID: 5651373
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral vascular actions of alpha-methyldopa in the dog.
    Rodrigues-Pereira E
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):105-15. PubMed ID: 201221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.